Expanded Access Study of Talimogene Laherparepvec of Subjects in Europe with late stage Melanoma

Update Il y a 5 ans
Reference: EUCTR2014-002834-30

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To provide access of talimogene laherparepvec for subjects with unresected stage IIIB to IVM1c melanoma in select countries in Europe until marketing authorization approval by the European Commission for the treatment of melanoma


Inclusion criteria

  • Unresectable, Stage IIIB to IVM1c Melanoma

Links